Pfizer Collaborates with Vivet to Develop Gene Therapy for Wilson Disease
By Rajaneesh K Gopinath, Ph.D. The US pharma giant struck a deal by buying 15% equity interest in the French biotech company, headquartered in Paris for US$51 million, and also …
Read More